Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SoftMedX HealthcareHKSE:00648 -0.88%54 Days Payable is 72.95 as of Jun. 2026, which is 0% below its 10-year median of 73.14. GuruFocus rates HKSE:00648 with a GF Score™ of 54/100 and a GF Value™ of HK$2.52 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 610 Healthcare Providers & Services companies, SoftMedX Healthcare ranks better than 53.44% on this metric.
The historical rank and industry rank for SoftMedX Healthcare's Days Payable or its related term are showing as below:
HKSE:00648'
s Days Payable Range Over the Past 10 Years
Min: 18.74 Med: 73.14 Max: 1181.33
Current: 61.44
During the past 13 years, SoftMedX Healthcare's highest Days Payable was 1181.33. The lowest was 18.74. And the median was 73.14.
HKSE:00648's Days Payable is ranked better than 53.44% of 610
companies
in the Healthcare Providers & Services industry
Industry Median: 58.02
vs HKSE:00648: 61.44
SoftMedX Healthcare's Days Payable
increased
from Jun. 2025 (52.15) to Jun. 2026 (72.95).
It may suggest that SoftMedX Healthcaredelayed paying its suppliers.
The historical data trend for SoftMedX Healthcare's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00648 vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, SoftMedX Healthcare's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SoftMedX Healthcare Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SoftMedX Healthcare's Days Payable distribution charts can be found below:
* The bar in red indicates where SoftMedX Healthcare's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
SoftMedX Healthcare's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SoftMedX Healthcare (HKSE:00648) has a Days Payable of 72.95 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SoftMedX Healthcare and its competitors. This is near median its historical median of 73.14. Over the past decade, SoftMedX Healthcare's Days Payable has ranged from 18.74 to 1,181.33. According to the industry distribution chart, SoftMedX Healthcare ranks #284 out of 610 companies in the Healthcare Providers & Services industry, placing it in the top 46.6%.
Is SoftMedX Healthcare's Days Payable too high?
SoftMedX Healthcare's current Days Payable of 72.95 is near median its 10-year median of 73.14. Over the past 10 years, this metric has ranged from a low of 18.74 to a high of 1,181.33. The Healthcare Providers & Services industry median Days Payable is 58.02. SoftMedX Healthcare's value of 72.95 is 25.7% above this industry median. Based on the distribution chart, SoftMedX Healthcare ranks #284 out of 610 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, SoftMedX Healthcare has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SoftMedX Healthcare's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, SoftMedX Healthcare ranks #284 out of 610 companies for Days Payable. This puts SoftMedX Healthcare in the upper half of its industry. The industry median Days Payable is 58.02. SoftMedX Healthcare's value of 72.95 is 25.7% above this benchmark. Historically, SoftMedX Healthcare's own Days Payable has ranged from 18.74 to 1,181.33 over the past decade. While the company's 10-year median is 73.14 vs. the industry median of 58.02, SoftMedX Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.02, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SoftMedX Healthcare's current Days Payable of 72.95 is 25.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SoftMedX Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SoftMedX Healthcare's current Days Payable is 72.95, which is near median its own 10-year median of 73.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SoftMedX Healthcare stock overvalued right now?
Based on GuruFocus' analysis, SoftMedX Healthcare (HKSE:00648) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.52, compared to a current price of HK$0.56 — trading 77.8% below its estimated fair value. The current Days Payable is 72.95, which is near median its 10-year median of 73.14 and 25.7% above the Healthcare Providers & Services industry median of 58.02. SoftMedX Healthcare's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For SoftMedX Healthcare (HKSE:00648), the current Days Payable is 72.95 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SoftMedX Healthcare (HKSE:00648) Overvalued in 2026?
Based on GuruFocus' analysis, SoftMedX Healthcare stock appears to be undervalued.
The current stock price of HK$0.56 is trading 77.8% below its estimated GF Value™ of HK$2.52.
GuruFocus considers SoftMedX Healthcare to be Possible Value Trap.
Key valuation signals for HKSE:00648:
Days Payable: 72.95 (near median its 10-year median of 73.14)
GF Value™: HK$2.52 vs. price of HK$0.56 (77.8% below fair value)
Industry Position: 25.7% above the Healthcare Providers & Services median (#284 of 610)
No single metric tells the full story. See the HKSE:00648 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SoftMedX Healthcare Ltd is principally engaged in the distribution of medical and healthcare equipment and products. The Group has one reportable operating segment: medical and well-being business, for the Distribution of medical and healthcare equipment and products.
54GF Score
Get the complete analysis for HKSE:00648
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00648 has been successfully added to your 
